Select your Market

Africa
- Algeria
- Angola
- Benin
- Botswana
- Burkina Faso
- Burundi
- Cameroon
- Cape Verde
- Central African Republic
- Chad
- Comoros
- Congo
- Congo Democratic Republic
- Djibouti
- Egypt
- Equatorial Guinea
- Eritrea
- Ethiopia
- Gabon
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Ivory Coast
- Kenya
- Lesotho
- Liberia
- Libya
- Madagascar
- Malawi
- Mauritania
- Mauritius
- Morocco
- Mozambique
- Namibia
- Niger
- Nigeria
- Reunion Islands
- Rwanda
- Saint Helena
- São Tomé and Príncipe
- Senegal
- Seychelles
- Sierra Leone
- Somalia
- South Africa
- Sudan
- Swaziland
- Tanzania
- Togo
- Tunisia
- Uganda
- Zambia
- Zimbabwe
Asia
- Bahrain
- Bangladesh
- China, mainland
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kuwait
- Lebanon
- Malaysia
- Oman
- Palestine
- Philippines
- Qatar
- Saudi Arabia
- Singapore
- South Korea
- Syria
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- Vietnam
- Yemen
Europe
- Albania
- Austria
- Baltic Region
- Belarus
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Netherlands
- North Macedonia
- Norway
- Poland
- Portugal
- Romania
- Russian Federation
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Türkiye
- Ukraine
- United Kingdom
Latin America
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Central America
- Chile
- Colombia
- Costa Rica
- Cuba
- Curacao-NL Antillen
- Ecuador
- El Salvador
- Guatemala
- Haiti
- Honduras
- Jamaica
- Mexico
- Nicaragua
- Panama
- Paraguay
- Perú
- República Dominicana
- Trinidad and Tobago
- Uruguay
- Venezuela
North America
- Canada
- United States of America
Oceania
- Australia
- New Zealand

[TITLE]

[TEASER]

Locations

[FULL TEXT]

Related News

Press Releases

Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained ...

The company announced today new two-year follow up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with TGCT.

2026/10/26